APA (7th ed.) Citation

Akatani, R., Chihara, N., Koto, S., Mori, S., Kurimoto, T., Nakamura, M., . . . Matsumoto, R. (2024). Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: A prospective cohort study. Immunological medicine, 47(2), 85-92. https://doi.org/10.1080/25785826.2024.2304364

Chicago Style (17th ed.) Citation

Akatani, Ritsu, et al. "Efficacy and Safety of Mycophenolate Mofetil for Steroid Reduction in Neuromyelitis Optica Spectrum Disorder: A Prospective Cohort Study." Immunological Medicine 47, no. 2 (2024): 85-92. https://doi.org/10.1080/25785826.2024.2304364.

MLA (9th ed.) Citation

Akatani, Ritsu, et al. "Efficacy and Safety of Mycophenolate Mofetil for Steroid Reduction in Neuromyelitis Optica Spectrum Disorder: A Prospective Cohort Study." Immunological Medicine, vol. 47, no. 2, 2024, pp. 85-92, https://doi.org/10.1080/25785826.2024.2304364.